©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109378
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109378
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109378
Figure 1 Effects of rapamycin on HUTU 80 cells proliferation.
A: Methylthiazolyldiphenyl-tetrazolium bromide assay was used to assess the effect of rapamycin (RAPA) on the proliferation of HUTU 80 cells at 48 hours; B: Calculation of the IC50 of RAPA on cells after 48 hours; C: Colony formation assay was used to assess the effect of RAPA on cell proliferation; D: Colony statistical chart. Data are presented as the mean ± SD (n = 3). aP < 0.05. bP < 0.01. cP < 0.001. RAPA: Rapamycin; NS: No significance.
- Citation: Pu BP, Wang PH, Guo KK, Liu C, Chen SR, Li XM, Chen SM, Zeng XZ, Gao C. Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1α mediated metabolic reprogramming. World J Gastrointest Oncol 2025; 17(9): 109378
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109378.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109378